How To Treat Neuroendocrine Tumors

Targeted Therapy

Targeted therapy can be used in the treatment of a patient's neuroendocrine tumor. Treatment that works by targeting the tissue environment, proteins, or specific genes of the neuroendocrine tumor is called targeted therapy. This type of therapy is most effective at inhibiting the growth and metastasis of the malignant cells with the ability to reduce damage to healthy cells in the body. Everolimus is a type of targeted treatment therapy often used in individuals with advanced neuroendocrine tumors that affect the digestive tract, pancreas, and lung. Everolimus is known to help inhibit the growth of an individual's neuroendocrine tumor, but it does not actually reduce the size of the tumor. Sunitinib is another type of targeted therapy that utilizes the presence of a protein called VEGF in the malignant cells of a neuroendocrine tumor in a patient's pancreas. Other types of targeted therapy are being tested in clinical trials that target neuroendocrine tumors by intervening in the process of new blood vessel development, or by blocking specific survival pathways of malignant cells.

Continue for more neuroendocrine tumor treatments now.